ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.154,79
0,00%
S&P 500
5.221,42
0,00%
US Dollar vs BRL
5,13033
-0,49%
Bitcoin
61.676,36
-1,95%
Brent Oil
82,385
-0,99%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Hercules Capital Inc (HTGC)

  7. Hercules Capital Inc (HTGC) Notícias

HTGC

Hercules Capital (HTGC)

Hercules Capital Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:HTGC
DataHoraFonteTítuloCódigoCompanhia
14/05/202409:00PR Newswire (US)Harness Raises $150 Million in New FinancingNYSE:HTGCHercules Capital Inc
13/05/202407:00Business WireHercules Capital Announces Date of 2024 Annual Meeting of StockholdersNYSE:HTGCHercules Capital Inc
09/05/202408:00GlobeNewswire Inc.Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERSNYSE:HTGCHercules Capital Inc
07/05/202407:00Business WireHercules Capital Announces Upcoming Event for the Financial CommunityNYSE:HTGCHercules Capital Inc
02/05/202417:05Business WireHercules Capital Reports First Quarter 2024 Financial ResultsNYSE:HTGCHercules Capital Inc
30/04/202407:00Business WireHercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024NYSE:HTGCHercules Capital Inc
30/04/202404:00PR Newswire (US)SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumabNYSE:HTGCHercules Capital Inc
24/04/202407:00Business WireHercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative OriginationsNYSE:HTGCHercules Capital Inc
18/04/202407:00Business WireHercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference CallNYSE:HTGCHercules Capital Inc
27/03/202407:00Business WireHercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.NYSE:HTGCHercules Capital Inc
21/03/202407:00Business WireHercules Capital Receives Confirmed BBB Investment Grade Rating with Revised Outlook to Positive from Morningstar DBRSNYSE:HTGCHercules Capital Inc
15/02/202418:31Edgar (US Regulatory)Form 8-K - Current reportNYSE:HTGCHercules Capital Inc
15/02/202418:07Business WireHercules Capital Reports Fourth Quarter and Full-Year 2023 Financial ResultsNYSE:HTGCHercules Capital Inc
13/02/202408:02Business WireHercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Fourth Quarter 2023NYSE:HTGCHercules Capital Inc
13/02/202408:00Business WireHercules Capital Announces New Supplemental Cash Distribution of $0.32 per ShareNYSE:HTGCHercules Capital Inc
30/01/202419:40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:HTGCHercules Capital Inc
25/01/202408:00Business WireHercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2023 Financial Results and Conference CallNYSE:HTGCHercules Capital Inc
23/01/202418:05GlobeNewswire Inc.Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules CapitalNYSE:HTGCHercules Capital Inc
22/01/202413:23Edgar (US Regulatory)Form ABS-15G - Asset-backed securitizer report pursuant to Section 15GNYSE:HTGCHercules Capital Inc
17/01/202421:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
02/01/202404:00GlobeNewswire Inc.Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules CapitalNYSE:HTGCHercules Capital Inc
22/12/202319:00PR Newswire (US)enGene Announces Expanded $50 Million Debt Facility with Hercules CapitalNYSE:HTGCHercules Capital Inc
14/12/202310:00GlobeNewswire Inc.Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules CapitalNYSE:HTGCHercules Capital Inc
09/11/202318:10Business WireHercules Capital Receives SBA “Green Light” Letter to Submit Its Fourth SBIC License ApplicationNYSE:HTGCHercules Capital Inc
08/11/202308:00Business WireHercules Capital Announces Upcoming Events for the Financial CommunityNYSE:HTGCHercules Capital Inc
02/11/202317:10Business WireHercules Capital Reports Third Quarter 2023 Financial ResultsNYSE:HTGCHercules Capital Inc
31/10/202307:00Business WireHercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2023NYSE:HTGCHercules Capital Inc
19/10/202313:14Edgar (US Regulatory)Form 40-17G - Fidelity Bond [Rule 17G-1(g)]NYSE:HTGCHercules Capital Inc
12/10/202307:00Business WireHercules Capital Announces Date for Release of Third Quarter 2023 Financial Results and Conference CallNYSE:HTGCHercules Capital Inc
04/10/202307:00Business WireHercules Capital Receives Reaffirmed Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors ServiceNYSE:HTGCHercules Capital Inc
 Apresentando as notícias mais relevantes sobre:NYSE:HTGC

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
ENJU3
Enjoei ON
BOV
IRBR3
IRB BRASIL ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
COGN3
COGNA ON
BOV
OIBR3
OI ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
POSI3
POSITIVO TEC ON
BOV
TECN3
TECHNOS ON
BOV
TELB4
TELEBRAS PN
BOV
FESA4
FERBASA PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados